Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in Japan.

Yuya NishidaTomoya MitaMakoto HikiYasushi MatsushitaToshio NaitoHirotaka Watada

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

Glucose abnormality, particularly BG ≥ 140 mg/dl, was associated with serious outcomes among Japanese COVID-19 patients, suggesting the need to consider high BG as a major risk factor for poor clinical course also in Japan.

Keyphrases

sars cov
coronavirus disease
blood glucose
type diabetes
glycemic control
metabolic syndrome